Actively Recruiting

Age: 18Years - 100Years
All Genders
NCT00646022

Natural History of Familial Carcinoid Tumor

Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-05-12

1600

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will evaluate members in families with a history of small bowel carcinoid cancer to study the natural history of those family members that have the disease, determine ways to improve early detection by performing surveillance on those at risk but without disease and to identify the gene(s) that may cause the tumors. Familial carcinoid tumors usually originate in hormone-producing cells that line the small intestine or other cells of the digestive tract. The tumors are slow-growing and usually take many years before they cause symptoms. It is known that these tumors occur more often in some families and are then passed from one generation to the next by inherited genes. Members of families, including all siblings and offspring in which two or more immediate blood relatives have had small bowel carcinoid tumors are eligible for this study. In some cases unaffected spouses of family members diagnosed with carcinoid cancer are also requested to participate by donating a sample of blood only. Participants undergo a medical evaluation every 3 years during a 3- to 5-day hospital stay at the NIH Clinical Center. All participants have a personal and family medical history obtained and undergo a physical examination, blood and urine tests. People who already have a small bowel carcinoid tumor or are at risk of developing a carcinoid tumor have some or all of the following procedures to determine the presence of carcinoid tumor and its (omit next two words- location or) spread to other areas of the body: * Video Capsule Endoscopy: Visualization of the gastrointestinal tract by ingesting a disposable, "vitamin-pill sized" video capsule that has its own camera and light source. * CT of the chest abdomen and pelvis with oral and IV contrast : X-ray examination of the chest, abdominal and pelvis organs. * 18 FDOPA Positron emission tomography (PET) with CT for localization: Nuclear imaging scan to look at tumor activity. * MRI Liver with contrast - to determine if disease has spread to liver * Gallium 68 PET/CT-limited to individuals that have residual tumor. * Clinical and research blood work Should mid gut carcinoid tumors be found every participant will be assisted in determine what the best course of treatment will be for them.

CONDITIONS

Official Title

Natural History of Familial Carcinoid Tumor

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female subjects 18 years of age or older
  • Diagnosis of small intestinal carcinoid tumor with at least one blood relative diagnosed with small intestinal, pulmonary, kidney, gastropancreatic neuroendocrine tumor, or metastatic neuroendocrine tumor of unknown primary
  • Male and female subjects 18 years of age or older with multiple synchronous primary small intestinal tumors
  • Male and female subjects 18 years of age or older without carcinoid tumor but with either at least two blood relatives diagnosed with relevant neuroendocrine tumors or at least one blood relative with multiple synchronous primary small bowel tumors
  • Male and female subjects 18 years of age or older not biologically related to the family but with offspring who are blood relatives of a participating subject
Not Eligible

You will not qualify if you...

  • Members of families with multiple endocrine neoplasia (MEN) I or II, Von Hippel Lindau Syndrome, Neurofibromatosis type I or II, or other familial tumor syndromes with known genetic predisposition to non-carcinoid and carcinoid tumors
  • Any condition that the investigator believes makes participation unsafe or prevents protocol completion
  • Inability to provide informed consent (Arm 1 only)
  • Pregnant or breastfeeding (Arm 1 only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

J

Joanne Forbes, C.R.N.P.

CONTACT

S

Stephen A Wank, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here